Shares of Cogent Biosciences surged in 2025 as enthusiasm mounted over its lead drug candidate, and four top-ranking ...

Highly rated Eli Lilly stock is this week's Big Cap 20 pick to watch as it attempts to take out a flat-base buy point.

The terms of the agreement entail that Eli Lilly and Company (NYSE:LLY) would acquire all the outstanding shares of Ventyx ...

Niagen Bioscience continues to see improving demand for Tru Niagen, strengthening cash generation, and a debt-free balance ...

Why Arcus Biosciences is on investors’ radar today Arcus Biosciences (RCUS) has drawn fresh attention after recent trading left the stock with a mixed return profile, including a 16.4% decline over ...

NovaBridge stock was trading higher Tuesday but has since reversed and begun trading lower. NovaBridge announced upgrade results from the Phase 1b combination study of givastomig.

Shares of Pacira BioSciences slipped after the company's preliminary-revenue report came in below Wall Street estimates. The stock fell 9.7%, to $23.49, in after-hours trading Thursday. Through the ...

Investing.com -- Ventyx Biosciences (NASDAQ:VTYX) stock surged 5% and was halted for volatility following reports that Eli Lilly (NYSE:LLY) is in advanced talks to acquire the biotech company for more ...

D. Boral Capital upgraded Artelo Biosciences, Inc. (NASDAQ:ARTL) on Tuesday. The analyst upgraded from Hold to Buy and introduced a price forecast of $20. Analyst Jason Kolbert wrote, “We continue to ...

It is being acquired for quite a meaty premium. The buyer is a top name in the global pharmaceuticals space. The purchasing party is global pharmaceutical company Novartis, which on Sunday divulged ...

Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some of ...